U.S. flag

An official website of the United States government

NM_000085.5(CLCNKB):c.1325A>G (p.Glu442Gly) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Aug 11, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000991835.6

Allele description [Variation Report for NM_000085.5(CLCNKB):c.1325A>G (p.Glu442Gly)]

NM_000085.5(CLCNKB):c.1325A>G (p.Glu442Gly)

Genes:
LOC106501713:CLCNKB recombination region [Gene]
CLCNKB:chloride voltage-gated channel Kb [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_000085.5(CLCNKB):c.1325A>G (p.Glu442Gly)
HGVS:
  • NC_000001.11:g.16051737A>G
  • NG_013079.1:g.12986A>G
  • NG_042865.1:g.7245A>G
  • NM_000085.5:c.1325A>GMANE SELECT
  • NM_001165945.2:c.818A>G
  • NP_000076.2:p.Glu442Gly
  • NP_001159417.2:p.Glu273Gly
  • NC_000001.10:g.16378232A>G
  • NC_000001.10:g.16378232A>G
  • NM_000085.3:c.1325A>G
Protein change:
E273G
Links:
dbSNP: rs1180658535
NCBI 1000 Genomes Browser:
rs1180658535
Molecular consequence:
  • NM_000085.5:c.1325A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165945.2:c.818A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001143609Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Likely pathogenic
(Oct 16, 2018)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV002246402Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 11, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A labor- and cost-effective non-optical semiconductor (Ion Torrent) next-generation sequencing of the SLC12A3 and CLCNKA/B genes in Gitelman's syndrome patients.

Tavira B, Gómez J, Santos F, Gil H, Alvarez V, Coto E.

J Hum Genet. 2014 Jul;59(7):376-80. doi: 10.1038/jhg.2014.37. Epub 2014 May 15.

PubMed [citation]
PMID:
24830959

ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3.

Andrini O, Keck M, Briones R, Lourdel S, Vargas-Poussou R, Teulon J.

Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1324-34. doi: 10.1152/ajprenal.00004.2015. Epub 2015 Mar 25. Review.

PubMed [citation]
PMID:
25810436
See all PubMed Citations (7)

Details of each submission

From Athena Diagnostics, SCV001143609.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

The best available variant frequency is uninformative because there are too few occurrences in population data. Found in at least one symptomatic patient. Predicted to have a damaging effect on the protein. Inconclusive functional study. Occurs in three or more cases with a recessive pathogenic variant in the same gene.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002246402.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces glutamic acid with glycine at codon 442 of the CLCNKB protein (p.Glu442Gly). The glutamic acid residue is highly conserved and there is a moderate physicochemical difference between glutamic acid and glycine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individuals with Bartter syndrome (PMID: 24058621). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 804713). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCNKB protein function. Studies have shown that this missense change alters CLCNKB gene expression (PMID: 28555925). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024